Paradigm-Therapeutics.com
About Paradigm-Therapeutics.com
TCB and its subsidiary TSP, have established world-class target identification and validation capabilities. Together they have developed a promising pipeline of novel drug discovery targets and compounds in such key areas of unmet medical need as CNS disorders, endocrinology and metabolic-related diseases.
